
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
TrialAssure, a global company focused on developing clinical trial transparency tools, announced that it will partner with Otsuka Pharmaceutical Development and Commercialization, Inc. to implement its comprehensive transparency management system for all compounds in Otsuka’s drug development pipeline.
Read the full release






